Allergan has launched www.BIOCELLinformation.com, an online resource for patients, surgeons and healthcare professionals related to the voluntary global recall of BIOCELL textured breast implants and tissue expanders announced on July 24, 2019. The website offers detailed information and specific guidance about the recent announcement, including the latest resources on the BIOCELL withdrawal and warranty information.
The site includes features such as tools and visuals to help patients understand what a textured implant is and how to read patient implant cards. Healthcare providers will find tools to help guide the identification of patients with BIOCELL textured devices, including a video resource and directions how to find patient information, and instructions how to return unused BIOCELL implants.
“Patient safety is a priority for Allergan,” said Charles Hugh-Jones MD, FRCP, Allergan’s chief medical officer. “We are committed to providing patients, surgeons and healthcare providers with the very latest information about the BIOCELL withdrawal with this new site.”
(The FDA and other health authorities have not recommended removal or replacement of textured breast implants or tissue expanders in asymptomatic patients.)